Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different-dose nalmefene combined with sufentanil in elderly perioperative patients
ChiCTR2000034772Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Jul 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of nalmefene and sufentanil in postoperative pain, post-operative cognitive decline (POCD), Postoperative gastrointestinal dysfunction (POGD) and 1 more (2 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoints: Time to Aldrete score at least 9 after PACU admission, Incidence of postoperative gastrointestinal dysfunction and 1 more. Started Jul 2020; status: recruiting.
02
Drugs
nalmefenesufentanil
03
Conditions
postoperative painpost-operative cognitive decline (POCD)Postoperative gastrointestinal dysfunction (POGD)postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2000034772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034772.